The original DESMOND randomised controlled trial in 2005/2006 demonstrated that the Newly Diagnosed patient course has the potential to improve patient outcomes by promoting positive changes in illness beliefs, weight reduction, smoking cessation, reduction in levels of depression and increased levels of physical activity and a decrease in cardiovascular risk score. The trial investigated patients newly diagnosed with diabetes.
The DESMOND Foundation Study is evaluating the effectiveness of the Foundation patient course in people with a HbA1c over 7% who have had Type 2 diabetes for at least a year. To make the results generalisable, a mixed ethnic population is being studied. The study is part of the Leicestershire, Northamptonshire and Rutland CLAHRC portfolio of studies and is being run in collaboration with Birmingham and Black Countries CLAHRC.
The study is a cluster randomised controlled trial with randomisation at practice level. Thirty one practices were recruited to refer patients and in total 370 people have been recruited. Participants are receiving standard routine care in the control arm, or standard routine care plus the DESMOND Foundation programme in the intervention arm. Collection of the follow-up data will be complete in September 2013 and the results will be reported in early 2014.
The Principle Investigator is Professor Melanie Davies, University of Leicester. If you require any information please contact Helen Dallosso (Helen.firstname.lastname@example.org; 0116 2584738) or Ginny Kilgallen Ginny.email@example.com; 0116 2588806)